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The RECK tumor-suppressor protein binds and stabilizes
ADAMTS10
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ABSTRACT
The tumor suppressor protein RECK has been implicated in the
regulation of matrix metalloproteinases (MMPs), NOTCH-signaling and
WNT7-signaling. It remains unclear, however, how broad the spectrum
of RECK targets extends. To find novel RECKbinding partners, we took
the unbiased approach of yeast two-hybrid screening. This approach
detected ADAMTS10 as a RECK-interactor. ADAMTS10 has been
characterized as a metalloproteinase involved in fibrillin-rich microfibril
biogenesis, and its mutations have been implicated in the connective
tissue disorder Weill-Marchesani syndrome. Experiments in vitro using
recombinant proteins expressed in mammalian cells indicated that
RECK indeed binds ADAMTS10 directly, that RECK protects
ADAMTS10 from fragmentation following chemical activation and that
ADAMTS10 interferes with the activity of RECK to inhibit MT1-MMP. In
cultured cells, RECK increases the amount of ADAMTS10 associated
with the cells. Hence, the present study has uncovered novel
interactions between two molecules of known clinical importance,
RECK and ADAMTS10.
This article has an associated First Person interviewwith the first author
of the paper.
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INTRODUCTION
RECK was initially isolated as a transformation suppressor gene
against the v-K-ras oncogene (Takahashi et al., 1998); subsequent
studies implicated RECK in suppression of tumor growth,
angiogenesis, invasion, metastasis and recurrence (Hill et al., 2011;
Noda and Takahashi, 2007; Oh et al., 2001; Yoshida et al., 2012).
RECK is conserved from insects to mammals as a single gene. Human
RECK encodes a glycosylphosphatidylinositol (GPI)-anchored
glycoprotein of ∼125 kDa with a weak matrix metalloproteinase
(MMPs) inhibitory activity (Miki et al., 2007; Oh et al., 2001; Omura
et al., 2009; Takahashi et al., 1998). Reck-deficient mice die around
embryonic day 10.5 (E10.5) with reduced tissue integrity, arrested
vascular development (Oh et al., 2001) and precocious neuronal
differentiation (Muraguchi et al., 2007). Some of these phenotypes
have been attributed to increased proteolysis (Oh et al., 2001),
attenuated Notch-signaling (Muraguchi et al., 2007) and reduced
WNT7-signaling (Noda et al., 2016; Vanhollebeke et al., 2015);
however, it remains unclear to what extent these mechanisms explain
the Reck mutant phenotypes. Tissue inhibitors of metalloproteinases
(TIMPs) are known as a prototypic family of endogenous MMP
inhibitors which are structurally unrelated to RECK. Mice lacking all
TIMPs (quadruple mutant) are viable (Shimoda et al., 2014),
demonstrating distinct physiological roles for TIMPs and RECK.
ADAMTS (a disintegrin-like and metalloprotease with
thrombospondin motifs) superfamily of secreted proteins consists of
19 zinc metalloproteinases and 7 ADAMTS-like proteins lacking
catalytic activity. A hallmark of ADAMTS proteases is an ancillary
domain containing one or more thrombospondin type 1 repeats
(TSR1). Known functions of ADAMTS proteases include maturation
of procollagen (ADAMTS2, 3 and 14) and von Willebrand factor
(ADAMTS13) as well as extracellular matrix (ECM) cleavage
involved in morphogenesis (nematode ADAMTS proteins),
angiogenesis (ADAMTS1 and 9), ovulation (ADAMTS1), cancer
(ADAMTS4, 5, 9 and 15) and arthritis (ADAMTS5) (Apte, 2009;
Hubmacher and Apte, 2015). The first biochemical study of
ADAMTS10 by Somerville et al. (2004) indicated that the gene is
widely expressed in mouse embryos particularly in mesenchymal
cells, that zymogen as well as processed forms of ADAMTS10 are
secreted from the cells, and that substantial amounts of these protein
species are retained in the pericellular region by interactionwith either
the cell surface or pericellular matrix components. Most ADAMTS
proteases contain a consensus furin recognition and cleavage
sequence (R-X-R/K-R↓) at the junction of the propeptide and
catalytic domain, butADAMTS10diverges at this site (i.e. GLKR233)
and lacks a sequence required for efficient cleavage by furin and other
members of the subtilisin/kexin-like proprotein convertase (PC)
family (Duckert et al., 2004), making it likely that ADAMTS10 is
resistant to activation by all PCs and activated by other means. The
discoveries that a rare connective tissue disorder, Weill-Marchesani
syndrome, was genetically linked with recessive mutations of
ADAMTS10 (WMS1; OMIM #277600) (Dagoneau et al., 2004) as
well as dominant mutations of fibrillin-1 (WMS2; OMIM #608328)
(Faivre et al., 2003) suggested that ADAMTS10 and fibrillin-1
(FBN1)might interact and/or act cooperatively in a common pathway.
In the present study, we performed yeast two-hybrid screening to
find clues to the additional molecular functions of RECK, and this led
to the detection of ADAMTS10 as a RECK-interactor. Experiments
with purified recombinant proteins and in cultured cells also yielded
evidence indicating physical and functional interactions between
these molecules of known, but distinct, clinical importance.
RESULTS
RECK binds ADAMTS10
In an attempt to find novel binding partners for RECK, we used the
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screen a mouse embryo cDNA library. Among the 14 positive
clones isolated and sequenced (Table S1), two independent clones
(clones 2 and 10) were found to encode overlapping, COOH-
terminal portions (129 and 251 amino acid residues, respectively) of
ADAMTS10 (see the bottom of Fig. 1B for their positions).
To map the domains responsible for this interaction, we
constructed a series of deletion mutants of both RECK (Fig. 1A,
Rd1-9) and ADAMTS10 (Fig. 1B, Ad1-6) and tested their
interactions again using the yeast two-hybrid assay. When the
near full-length ADAMTS10 (AF: residues 25-1104) was used as
bait (Fig. 1A), the RECK fragment Rd7 (residues 349-629) was
strongly positive, but full length RECK (RF) and the other RECK
fragments were negative under these stringent conditions: namely,
LTAH (−)+10 mM 3AT (see Materials and Methods for details).
When the near full-length RECK (RF: residues 27-942) was used as
bait (Fig. 1B), ADAMTS10 fragment Ad4 (residues 823-1104) was
strongly positive and Ad3 (residues 691-1104) was also clearly
positive. While in the settings shown in Fig. 1A and B, the
interaction between AF and RF was undetectable (Fig. 1A,B, top
row in the tables), under less stringent conditions (condition III in
Fig. 1C) their interaction was readily detected when we used RF as
bait and AF as prey (Fig. 1C, row 2). Likewise, the interaction
between two small fragments, Ad4 (bait) and Rd7 (prey), could be
detected (Fig. 1C, row 6). These results implicate a central region of
RECK and a C-terminal region of ADAMTS10 in this interaction
(Fig. 1D).
To verify the interaction more directly, we expressed a full-length
ADAMTS10 protein tagged with C-terminal tandem MYC and
His6 epitopes in the mammalian cultured cell line HEK293 and
purified this protein, termed ATS10-MH, from the culture
Fig. 1. RECK binds ADAMTS10. (A) Interactions between ADAMTS10 and various fragments of RECK. Yeast two-hybrid assays were performed using
near full-length ADAMTS10 (AF) as bait and the near full-length RECK (RF) or one of its fragments (Rd1-9) as prey. Structural features of RECK are shown
in the top-left diagram. SPI, Kazal type serine protease inhibitor. The experimental setting is shown in the top-right diagram. BD: DNA-binding domain. AD:
transactivation domain. (B) Interactions between RECK and various fragments of ADAMTS10. Yeast two-hybrid assays were performed using RF as bait
and AF or one of its fragments (Ad1-6) as prey. Structural features of ADAMTS10 are shown in the top left diagram. TSR, thrombospondin type 1 repeat;
PLAC, protease and lacunin. The experimental outline is shown in the top right diagram. In A and B, the growth (number of colonies) on selective plates is
presented as follows: −, no colonies; +, a few colonies; ++, more than 50% of the control (colonies on -LT plate); +++, more than 90% of the control. The
regions contained in the original two clones (2 and 10) isolated in library screening (see Table S1) are also shown (bottom). (C) Two-hybrid assays under
reduced stringency. Yeast cells transformed with a plasmid expressing a bait (RF or Ad4) were further transformed with a vacant vector (V) or the vector
expressing a prey (AF, Ad4, RF or Rd7) and selected with SD medium lacking two amino acids, leucine and tryptophan (LT). The selected colonies were
cultured in liquid SD medium lacking LT [termed LT (−) medium] overnight, and an equal amount of yeast suspension was plated on agar plates of either LT
(−) medium (Condition I), SD medium lacking adenine, histidine, leucine and tryptophan [LTAH (−) medium] (Condition II), LTAH (−) medium supplemented
with 2 mM 3AT (Condition III) or 5 mM 3AT (Condition IV) followed by incubation at 30°C for 7 days. Growth under Condition I indicates the presence of two
plasmids (bait and pray, respectively), while growth on other media indicates interactions between the bait and pray with weak (II) intermediate (III) and
strong affinities (IV). Note the higher background when RF was used as bait (II-1). (D) Summary of the results shown in A–C. (E) Dose-dependent binding of
ATS10-MH to immobilized RECK-His. See ‘Solid-phase binding assay’ in Materials and Methods for details. *P<0.05 against blank wells (non-coated dish;
n=3 wells). Similar results were obtained in three independent experiments.
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supernatant (Fig. S1A,C). We also raised antibodies (termed pAb-
867) against an epitope (residues 867-879) in the second TSR1
(Fig. S1A, arrow); they recognize both mouse and human
ADAMTS10. Using these reagents, together with a recombinant
RECK protein previously described (termed RECK-His; Fig. S1B,
D) (Omura et al., 2009), we could detect the direct binding between
ATS10-MH and RECK-His in a solid-phase binding assay in the
presence of three cations: Ca2+, Mg2+ and Zn2+ (Fig. 1E). Surface
plasmon resonance assay was also used to confirm this binding and
to reveal that the binding requires Zn2+ (Fig. S1E,F).
RECK co-localizes with ADAMTS10
Totally separate subcellular localization may preclude the physical
interaction between RECK and ADAMTS10 at the cellular level. To
test this possibility, we performed two types of double-labeling
experiments. First, immunofluorescence staining of endogenous
RECK (green) and ADAMTS10 (red) in mouse dermal fibroblasts
(MDFs), derived from wild-type mouse at postnatal day 3 (P3),
yielded yellow signals in the merged images (suggesting
co-localization) that were relatively rich in the peripheral and
peri-nuclear regions (Fig. 2A, panel 4; Movie S1); this pattern is
reminiscent of the RECK subcellular localization previously
observed in NIH3T3 cells (Morioka et al., 2009). We also noted
substantial heterogeneity in the levels of RECK expression among
theseMDFs (Fig. 2A, panel 2; note the green signals abundant in two
of the several cells in this field). This approach, however, depends on
the specificity of antibodies used (see Materials and Methods). We
therefore took the second approach of co-expressing two proteins
tagged with different fluorescent proteins, mRFP-RECK (red) and
GFP-ADAMTS10 (green), in a human osteosarcoma cell line (MG-
63) followed by confocal microscopy. This approach again yielded
yellow signals rich in the peri-nuclear region (Fig. 2B; Movie S2).
We also performed in situ proximity ligation assays (PLA), which
can detect close (<40 nm) co-localization between two molecules
(Söderberg et al., 2006). PLA demonstrated close co-localization
between endogenousRECKandADAMTS10 in amouse fibroblast-
derived cell line, NIH3T3 (Fig. 2C,D). These results support the idea
that RECK and ADAMTS10 may have chances to encounter and
interact with each other under physiological conditions.
Effects of RECK and ADAMTS10 on each other
ADAMTS10 is a protease (Apte, 2009; Hubmacher and Apte,
2015); RECK has been studied as a protease inhibitor (Miki et al.,
2007; Oh et al., 2001; Omura et al., 2009; Takahashi et al., 1998).
We therefore performed simple mix-and-incubation experiments
(Fig. 3A) to ask two obvious questions: (i) could ADAMTS10
cleave RECK? (ii) Could RECK inhibit ADAMTS10? In this
experiment, we tried to activate pro-ADAMTS10 using
p-aminophenyl mercuric acetate (APMA), a chemical known
to activate several other members of the metazincin family.
When RECK-His (125 kDa) was incubated alone or in the
presence of different amounts of ATS10-MH in buffer containing
APMA for 21 h and then visualized by immunoblot assay, a dose-
dependent increase in the density of ∼30 kDa fragment of RECK
(Fig. 3B, arrowheads) was detected (Fig. 3D), although the decrease
in full-length RECK band was not so prominent, suggesting that
ADAMTS10 has a weak activity to cleave RECK.
A previous study by Kutz and colleagues (Kutz et al., 2011) also
demonstrated that recombinant human ADAMTS10 gave rise to
multiple bands in immunoblot assays and this phenomenon required
its protease catalytic site (E393), suggesting that the phenomenon
represented autocatalytic fragmentation. ATS10-MH (derived from
mouse cDNA) shows two groups of prominent bands: one
corresponding to its pro-form and the other close to the size of the
mature form (I and II in Fig. 3C). When the amount of ATS10-MH
was increased, the overall density of immunoblot bands increased
up to a certain input protein concentration but did not increase at
a higher concentration (Fig. 3C, compare lanes 3, 5 and 7;
densitometric data in Fig. 3E, bars 3, 5 and 7). At the highest
ATS10-MH concentration, the density of bands I and II decreased
(Fig. 3E, bar 7 versus 5 in red and green) while the density of the
smaller fragments increased (Fig. 3E, bars 7 versus 5 in purple),
suggesting that ATS10-MH underwent dose-dependent
autocatalytic fragmentation (illustrated by the downward arrow in
Fig. 3F). In the presence of RECK-His, on the other hand, the
density of ATS10-MH bands increased (Fig. 3C, compare lanes 2, 4
and 6 to lanes 3, 5 and 7; Fig. 3E, bars 2, 4 and 6 versus bars 3, 5 and
7), suggesting that RECK-His stabilizes ATS10-MH under these
conditions (illustrated by the upward arrow in Fig. 3F). Similar
results were obtained in another independent experiment (Fig. S3).
The decrease in ATS10-MH band density at higher concentrations
and the effect of RECK-His to yield higher ATS10-MH band
density were clear only when APMA was added (Fig. S4B, lane 6
versus 3, lane 5 versus 6) and undetectable at an earlier time point
(1.5 h; Fig. S4C, lane 5 versus 7, lanes 4 and 6 versus 5 and 7).
Taken together, these results indicate that ATS10-MH has a weak
activity to cleave RECK-His and support the idea that RECK-His
inhibits the autocatalytic fragmentation of ATS10-MH (illustrated
in Fig. 3G).
Effects of ATS10-MH on RECK function
We next asked whether ATS10-MH affects the known function
of RECK to inhibit MMPs by mix-and-incubation experiments
with four purified factors (see Fig. 4A) in the absence of APMA.
Furin-activated MT1-MMP cleaves fibronectin (FN) into smaller
fragments as expected (Sternlicht and Werb, 2001) (Fig. 4B, lane 3
versus 1), and this reaction is inhibited by RECK-His (Fig. 4B,
compare the bracketed region of lanes 6 and 3; Fig. 4C, 6 versus 3).
In this system, ATS10-MH suppresses the effect of RECK-His
(Fig. 4B, compare the bracketed region of lanes 5 and 6; Fig. 4C,
lane 5 versus 6). One possibility is that ATS10-MH cleaves and
reduces the level of intact RECK-His, allowingMT1-MMP to freely
work again; however, RECK-His seems to be largely intact under
these conditions (Fig. 4F, lane 5 versus 6). A more feasible model is
that ATS10-MH binds RECK-His thereby interfering with the
interaction between MT-MMP and RECK-His. This experiment
also demonstrated the activity of MT1-MMP to efficiently cleave
ATS10-MH (Fig. 4D, lane 4 versus 2). These findings are
summarized in Fig. 4G.
Effects of RECK on ADAMTS10 associated with the cells
In an attempt to confirm the biological relevance of the above
findings using recombinant proteins, we prepared MDFs from mice
with four different RECK expression levels: 100% (+/+), ∼70%
(Low/+), ∼50% (+/Δ) and ∼20% (Low/Δ) (see Fig. S5A,B). Note
that among these mice, conspicuous developmental abnormalities
are found only in Low/Δ mice (Yamamoto et al., 2012) but more
subtle phenotypes, especially after damage, have been found in +/Δ
mice (Gutierrez et al., 2015; Wang et al., 2010). Confluent cultures
of these cells (three animals per genotype) were lysed and subjected
to immunoblot assay to detect RECK, ADAMTS10 and α-tubulin
(Fig. 5A). The level of RECK in the cell lysates decreased
in agreement with their genotypes (Fig. 5A, panel 2; densitometry
data in Fig. 5B, black bars). When the level of cellular RECK
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protein was low (≤50%: +/Δ and Low/Δ), the level of ADAMTS10
associated with the cells was significantly reduced (Fig. 5B, white
bars). Reduction of ADAMTS10 associated with MDFs derived
from Low/Δ mice (P3 and P5) could also be detected by
immunofluorescence staining (Fig. 5C,D). The level of
ADAMTS10 associated with BE6, a RECK-deficient MG-63
clone, was significantly lower and diffuse compared to the parental
line (Fig. 5E,F).
Taken together, our data indicate that RECK interacts with
ADAMTS10 and increases the level of ADAMTS10 associated
with the cells, possibly by protecting ADAMTS10 from
degradation (Fig. 5G).
Fig. 2. RECK co-localizes with ADAMTS10. (A) Immunofluorescence staining for endogenous ADAMTS10 (red, panel 3) and RECK (green, panel 2) in
wild-type MDFs. Nuclei were counterstained with Hoechst-33342 (blue, panel 1). A merged image is shown in panel 4. Scale bar: 20 µm. (B) Co-expression
of mRFP-RECK and GFP-ADAMTS10 in MG-63 cells. A confocal image (panel 1) and the Y-section (panel 2) and X-section (panel 3) images reconstituted
from the Z-series images are shown. Scale bar: 10 µm. Asterisk: a cell expressing both proteins. (C,D) In situ proximity ligation assays (PLA) using
antibodies against RECK (anti-R) and ADAMTS10 (anti-A) to detect close co-localization between endogenous ADAMTS10 and RECK proteins in/around
NIH3T3 cells. (C) Typical results of PLA. The PLA signals were detected in the presence of the indicated antibodies (green, upper panels) and recorded after
nuclear counterstaining (blue, lower panels). Scale bar: 100 µm. (D) The intensity of the PLA signals and the number of nuclei were quantified from images,
as shown in C, to calculate the signal intensity per cell (n=8). Conceptual experimental strategy is illustrated near each panel.
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DISCUSSION
Compelling evidence from experimental studies as well as analyses
of clinical specimens implicate RECK in tumor suppression
(Chung et al., 2012; Fakhry et al., 2016; Hill et al., 2011; Noda
and Takahashi, 2007; Yoshida et al., 2012). Previous biochemical
evidence led to the idea that competitive inhibition ofMMPsmay be
the major molecular basis of RECK’s biological functions. The
affinity of RECK for MMPs (Ki∼10−8) (Miki et al., 2007; Oh et al.,
2001; Omura et al., 2009; Takahashi et al., 1998), however, is lower
than that of the prototypic endogenous MMP inhibitors, TIMPs (Ki:
10−9-10−16 M) (Bourboulia and Stetler-Stevenson, 2010; Butler
et al., 1999; Murphy, 2011), raising the possibility that RECK may
have additional molecular functions. Our attempts to find novel
RECK-interactors using the unbiased approach of yeast two-hybrid
screening led to the detection of another new target, ADAMTS10, a
member of a metalloproteinase family distinct from MMPs.
Our experiments using recombinant proteins (i.e. ATS10-MH)
demonstrated dose-dependent auto-degradation of ADAMTS10
(see Fig. 3). We speculate that the large variability in its
RECK-binding activity observed at higher dosages in a solid-
phase binding assay (e.g. Fig. 1E, 0.5 unit) might reflect such auto-
degradation. In immunoblot assays, our preparations of ATS10-MH
consistently yielded two sets of major bands of ∼138 kDa (band I)
and ∼123 kDa (band II) (see Fig. 3C), and band II is likely to
Fig. 3. Effects of RECK-His and ATS10-MH on each other. (A) Experimental outline. ATS10-MH, at three different concentrations (relative concentration: 1, 2
and 4; see the section ‘Protein-mixing assay’ in Materials and Methods for detail), was incubated for 21 h without or with a constant amount of RECK-His in the
presence of APMA, and the reaction mixtures were subjected to immunoblot assay (IB) using anti-RECK (B) or anti-ADAMTS10 (C). (D) Density of RECK
fragment bands. Density of the full-length RECK-His (B, green arrow) and a fragment of ∼30 kDa (red arrowhead) in the blot shown in B were quantified using
ImageJ, and their ratios are presented. (E) Density of ADAMTS10 bands. Relative intensities of a band or a group of bands in C, as indicated by the symbols
(I,II and L), were quantified. The diamonds in C indicate samples containing RECK-His. See Fig. S3 for reproducibility and Fig. S4 for APMA- and time-
dependence of the results in C. (F) Conceptual diagram to explain the results in panel C. X-axis: concentration of ATS10-MH before incubation. Y-axis:
concentration of ATS10-MH after incubation. Red curve: ATS10-MH alone. Green curve: ATS10-MH with RECK-His. When incubated alone, the level of ATS10-
MH declined at the higher concentration range (red arrow), suggesting dose-dependent autocatalytic fragmentation. In the presence of RECK-His, such decline
was less prominent (green arrow), suggesting inhibition of ATS10 MH-fragmentation by RECK-His. (G) Summary of findings.
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contain activated ADAMTS10 (Somerville et al., 2004). Of note,
RECK-His not only increases the intensity of ATS10-MH but also
increases the relative intensity of band II to band I (see Fig. 3C;
e.g. compare lane 6 with lane 7), raising the possibility that RECK
may help generate and selectively stabilize the active form of
ADAMTS10. Such cooperative interaction is in sharp contrast to the
effect of RECK onMMPs (i.e. negative regulation) and is consistent
with our observation that RECK and ADAMTS10 promote fibrillin
microfibril formation in a cooperative manner in cultured cells
(T. Matsuzaki et al., unpublished).
Yeast two-hybrid assays indicated that RECK has the potential
to bind to a C-terminal portion, rather than the catalytic domain,
of ADAMTS10 (Fig. 1B–D). Ihara and Nishiwaki reported that
a nematode ADAMTS protein, MIG-17, undergoes autocatalytic
activation which requires its C-terminal PLAC domain and
suggested that this domain might interact with the
Fig. 4. Effects of RECK-His and ATS10-MH on FN-cleavage by MT1-MMP. (A) Experimental outline. FN was mixed with ATS10-MH, MT1-MMP
(furin-activated) and/or RECK-His in various combinations, incubated for 18 h, and the reaction mixture was subjected to immunoblot assay using anti-FN (B;
non-reducing conditions), anti-ADAMTS10 (D; reducing conditions), anti-MT1-MMP (E; non-reducing conditions) or anti-RECK (F; reducing conditions). (C)
Density of the monomer FN bands indicated by brown bracket in B. The data (mean±s.e.m.) from three independent experiments are shown. *P<0.05. Note
that ATS10-MH enables MT1-MMP to cleave FN even in the presence of RECK-His (diamond in B and C), that an ATS10-MH band of ∼123 kDa remains
after cleavage by MT1-MMP (arrowhead in D), that a RECK-His band of ∼50 kDa is produced by MT1-MMP (arrowhead in F), and that the intensity of the
full-length RECK-His band is slightly higher when ATS10-MH is present (arrow in F). (F) Schematic summary of the results.
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metalloproteinase domain to promote autocatalytic activation
(Ihara and Nishiwaki, 2007). Of note, the PLAC domain of
MIG-17 shows the highest similarity to that of mammalian
ADAMTS10 among all family members (Ihara and Nishiwaki,
2007). We therefore speculate that RECK may facilitate this
interaction while inhibiting the auto-degradation of once activated
ADAMTS10. The reason why this interaction requires Zn2+
is presently unclear. Metalloproteinases are known to coordinate
Zn2+ in their catalytic domain, and therefore Zn2+ may well
have allosteric effects on other domains. Alternatively, Zn2+ may
be required for this particular protein-protein interaction
more directly.
Some of our data demonstrated a weak, APMA-dependent
activity of ADAMTS10 to cleave RECK in a dose-dependent
manner (Fig. 3B). An activity of ADAMTS10 to suppress the
MMP-inhibiting activity of RECK was also found (Fig. 4B,C). In
these respects, ADAMTS10 may be considered as a regulator of
RECK’s functions.
Previous studies by Apte and colleagues (Kutz et al., 2008;
Somerville et al., 2004) raised several important questions about
the molecular nature of ADAMTS10, which include (1) why
ADAMTS10 undergoes extensive fragmentation, (2) why a large
fraction of ADAMTS10 forms aggregates in the culture supernatant,
and (3) why its pro-domain cannot be efficiently cleaved off by
furin. These questions are based mainly on the observations made
using the epithelial cell line HEK293F which expresses a minimal
level of RECK protein. Our findings that MT1-MMP efficiently
cleaves pro-ADAMTS10 yielding a fragment of about the size of
its active form (see Fig. 4D) and that RECK influences the
fragmentation of activated ADAMTS10 (see Fig. 3C,E–G) shed
some new light on these questions. In mouse embryos, RECK
expression is relatively high in mesenchymal cells in which
ADAMTS10 is also expressed abundantly (Somerville et al.,
2004). The fate of ADAMTS10 co-produced with RECK by
mesenchymal cells is likely to differ from that of ADAMTS10
produced by HEK293F cells. Whether such difference has to do
with the reported differences in the modes of microfibril formation
between mesenchymal and epithelial cells (Baldwin et al., 2014;
Cain et al., 2016) is an interesting issue to be addressed in future
studies.
In summary, this study has uncovered the novel ability of RECK
to interact with ADAMTS10, an enzyme known to be critical for
connective tissue development, and to increase the amount
of ADAMTS10 associated with the cell. This interaction may
also affect the function of RECK itself, a tumor suppressor
downregulated in a wide variety of cancers.
Fig. 5. Effects of reduced Reck expression on ADAMTS10 in cultured mesenchymal cells. (A,B) Immunoblot assay with MDF cell lysates. Primary
MDFs prepared from three animals of the indicated Reck genotypes were grown to confluence, and the cell lysates prepared from these cultures were
subjected to immunoblot assay using anti-ADAMTS10 (A-1) and anti-RECK (A-2) antibodies, respectively; the latter blot was re-probed with anti-α-tubulin
(TUBA) antibodies (A-3). The levels of RECK expression predicted from the genotype are schematically depicted in green above the blots. (B) Densitometry
of the RECK band (black bar) shown in A-2 and the ADAMTS10 band (white bar) shown in A-1 (brown arrow). The value from each lane was normalized
against that of TUBA and then divided by the mean value of +/+ samples. Bar represents mean±s.e.m. of three samples. *P<0.05, **P<0.01 (as compared
to +/+ MDFs). (C,D) Immunofluorescence staining of MDFs. MDFs prepared from Low/Δ and Low/+ (control littermate) mice at P3 or P5 were stained with
anti-ADAMTS10 antibodies (magenta) followed by nuclear counterstaining (blue) (C). Scale bar: 10 µm. Total fluorescence intensity of the images as shown
in C (n=8) was determined, and the values (mean±s.e.m.) are presented as a bar graph in D. **P<0.01 (between the mutant and control littermates).
(E,F) Immunofluorescence staining of MG-63 cells. MG-63 cells and its RECK-deficient derivative (BE6) were stained with anti-ADAMTS10 antibodies
(magenta) followed by nuclear counterstaining (blue). Images were recorded using a fluorescence microscope (Zeiss Axioplan). Total fluorescence intensity
of the images as shown in E (n=8) was determined using ImageJ and the values (mean±s.e.m.) are compared in F. *P<0.05. The levels of ADAMTS10
mRNA was not significantly different between these pairs of cells (data not shown). (G) Summary of findings.
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MATERIALS AND METHODS
Antibodies
Rabbit polyclonal anti-ADAMTS10 antibodies (pAb-867) were raised
against a synthetic oligopeptide (SGHSKLPKRQRAC; in the second TSR
domain). Other primary antibodies: mouse monoclonal antibodies against
RECK (5B11D12) (Takahashi et al., 1998), FN (610078, BD), MT1-MMP
(ab51074; Abcam) and α-tubulin (DM1A; Calbiochem/Merck Millipore,
Burlington, USA). Secondary antibodies: anti-rabbit IgG-HRP (ab6721;
Abcam), anti-mouse IgG-HRP (A4416; Sigma-Aldrich), anti-mouse
IgG-CF488 (20018; Biotium, Fremont, USA), anti-mouse IgG-CF405M
(20182, Biotium) and anti-rabbit IgG-CF647 (20282: Biotium). Antibody
dilution: primary 1:1000 and secondary 1:20000 for immunoblot assays,
primary 1:300 and secondary 1:1000 for immunofluorescence staining.
Specificity of pAb-867 and 5B11D12 in immunofluorescence staining
was assessed in MG-63 cells genetically manipulated to suppress
(ADAMTS10) or inactivate (RECK) the expression of endogenous target
genes (see Fig. S2).
Reck mutant mice
The Reck mutant allele, Δ (also known as Recktm2.2Noda) and Low (also
known as Recktm1.2Noda), have been described (de Almeida et al., 2015;
Chandana et al., 2010; Yamamoto et al., 2012) and were on the Mus
musculus C57BL/6 background. The animal experiments were approved by
the Animal Experimentation Committee, Kyoto University and conducted
in accordance with its regulations.
DNA construction
A mouse embryo (E12, C57BL/6) cDNA library (2×106 clones) was
generated using the pGADT7 vector. Lambda Zap II-based cDNA libraries
were also generated using the same cDNA pool and adult mouse brain
cDNAs. A fragment of mouse Reck cDNA (codons 27-942; termed RF) was
amplified by PCR (Table S2A), digested with EcoRI and SalI and inserted
into pGBKT7 to obtain pGBKT7-mRECK. A full-length Adamts10 cDNA
was re-screened from a Lambda Zap II-based library; its upstream sequence
(gcccctATGgct) was modified to make it better fit with the Kozak sequence
(gaattcgccATGgct), and it was inserted between the EcoRI and XbaI sites of
the pEF6/Myc-His A vector to obtain pEF6A-mAdamts10. To generate the
vector expressing ATS10-MH, pEF6A-mAdamts10 was modified so that
the termination codon of Adamts10was replaced in framewith the sequence
encoding the MYC-His6 epitope tag present in the pEF6/Myc-His A vector.
For protein production, the same coding sequence was inserted into
pTet-splice (Tet-off ) to obtain pTet-mAdamts10MycHis. For the yeast
two-hybrid assay, an Adamts10 cDNA (codons 25-1104; termed AF) was
amplified by PCR (Table S2A), digested with EcoR1 and Sal I and inserted
into pGBKT7 to obtain pGBKT7-mAdamts10. To generate cDNAs
encoding deletion mutants of RECK or ADAMTS10, the target
sequences were amplified by PCR and inserted into pGADT7 (Rd1-9 and
Ad1-6). Sources of vectors and hosts: pGBKT7 and pGADT7 (Clontech,
Palo Alto, USA), pEF6/Myc-His A (Invitrogen), lambda Zap II (Stratagene,
La Jolla, USA), pTet-splice (GIBCO) and the yeast strain AH109
(Clontech). pLXSB-hRECK has been described (Morioka et al., 2009;
Sasahara et al., 1999). To express EGFP-tagged ADAMTS10 protein in
mammalian cells, the Ad1 cDNA was inserted into pEGFP-C1 (Clontech)
containing the RECK signal peptide sequence (Morioka et al., 2009) to
obtain p-ss-EGFP-Adamts10. pmRFP-RECKwas also described previously
(Morioka et al., 2009).
Yeast two-hybrid assay
AH109 cells were transformed with pGBKT7-mRECK and selected on
SD plates without tryptophan to obtain the indicator strain AH109-mRECK.
To screen RECK-interactors (Table S1), AH109-mRECK cells were
transformed with the pGADT7-based cDNA library and selected on SD
plates without leucine, tryptophan, adenine, or histidine (-LTAH) and with
10 mM 3-amino-1,2,4-triazole (3AT; an inhibitor of histidine biosynthesis
which increases the stringency of selection in a dose-dependent manner)
for 11 days. For binding assays, the AH109 cells harboring pGBKT7-
mAdamts10 or pGBKT7-Ad4 were transformed with pGADT7-RECK
(RF) or its deletion mutants (Rd1-9), and their growth on SD (-LTAH) plates
with 3AT at different concentrations (0, 2, 5, 10) was examined after
incubation for 4 days (Fig. 1A,C). Similarly, AH109-mRECK cells
were transformed with pGADT7-mAdamts10 (AF) or its deletion mutants
(Ad1-6), and their growth on SD (-LTAH) plates with or without 3AT
was examined.
Cell culture and gene transfer
HEK293, MG-63 (ATCC) and NIH3T3 cells (a gift from Dr Robert
H. Bassin) were maintained in growth medium (GM) consisting of DMEM
supplemented with 10% fetal bovine serum (FBS), 100 µg/ml streptomycin
sulfate and 100 U/ml penicillin G. MDFs were prepared from mouse-back
skin (P3-P5) using the cold trypsin method (Freshney, 1987). Transfection
was performed using Lipofectamine 2000 (Invitrogen), FuGENE 6 (Roche)
or CalPhos Mammalian Transfection Kit (Clontech).
Recombinant ATS10-MH protein
HEK293 Tet-off Advanced (Clontech) was stably co-transfected with
pTet-mAdamts10MycHis and pEF6/Myc-His A, selected with 8 µg/ml
blasticidin in GM (selection medium), and a clone abundantly producing
ATS10-MH was maintained in selection medium containing 2 μg/ml
doxycycline. Subconfluent cultures of these cells were washed with PBS
and incubated in CD293 medium for 5 days. Culture supernatant was
centrifuged to remove cellular debris, dialyzed against PBS, adjusted to
0.5 M NaCl and applied to a His-Trap HP column (GE) that was
equilibrated with 20 mM imidazol. After washing with 40 mM imidazole,
proteins were eluted using a step-gradient of imidazole. The 60 mM
imidazol fraction rich in ATS10-MH was used in the solid-phase binding
assay after replacing its solvent with 20 mM Hepes (pH7.2), 150 mM
NaCl by ultrafiltration (AmiconUltra 50K; Millipore). The 250 mM
imidazole fraction was dialyzed against 0.15 M NaCl/20 mM KPO4
(pH 8.0) and applied to a cation-exchange column (RESOURCE S, GE).
The flow-through fraction was applied to an anion-exchange column
(RESOURCE Q, GE); the column was washed with 20 mM KPO4
(pH 8.0) containing 310 mM NaCl, and the bound proteins were eluted
sequentially using buffer containing 400 mM NaCl and 1 M NaCl,
respectively. The 400 mM NaCl fraction was used for the protein-mixing
assays shown in Fig. 4 and Fig. S4B. This fraction was further applied to
a gel filtration column (Hiload 26/60) to eliminate small molecules and
used for surface plasmon resonance assay. The 1 M NaCl fraction was
dialyzed against 20 mM Hepes (pH 7.0)/180 mM NaCl and applied to a
heparin HP column (GE), and the flow-through fraction was used for the
protein-mixing assays shown in Fig. 3 and Fig. S4D.
Solid-phase binding assay
Purified RECK-His protein (Omura et al., 2009) (100 ng/170 µl/well) was
immobilized onto 96-well Maxisorp Plates (Nunc/Thermo Fisher Scientific,
Waltham, USA) with 15 mM Na2CO3, 35 mM NaHCO3, 6 mM azide. The
wells were blocked with 1% bovine serum albumin (200 µl), washed with
PBS twice, and then with 20 mM Hepes pH7.4/150 mM NaCl (HBS).
ATS10-MH (after His-Trap purification from 400 ml culture supernatant
which yielded 3.2 ml buffer-exchanged sample – see the section
‘Recombinant ATS10-MH protein’ for details – 1 unit in Fig. 1E
correspond to undiluted sample) serially diluted in HBS containing 2 mM
CaCl2, 2 mMMgCl2, 2 nM ZnCl2 was added to the wells (170 µl/well) and
incubated overnight at 4°C. After extensive washing with PBS containing
0.0005% Tween 20 (WB), ATS10-MH bound to the well was labeled with
anti-ADAMTS10 and then with HRP-conjugated anti-rabbit IgG (Cell
Signaling Technology), and detected using chemiluminescent HRP
substrate (Immobilon Substrate, WBKLS0500, Millipore) followed by
luminometry (MicroLumatPlus, PerkinElmer, Waltham, USA).
Localization of RECK and ADAMTS10 in cultured cells
For immunofluorescence staining, wild-type MDFs were fixed in acetone at
−80°C and stained with anti-ADAMTS10 (pAb-867; CF647) (Fig. 5C,D) or
double-stained with anti-ADAMTS10 (pAb-867; CF647) and anti-RECK
(5B; CF488) (Fig. 2A). For co-expression of fluorescent-protein-tagged
proteins (Fig. 2B), MG-63 cells on 2-well chamber slides (SCS-002,
Matsunami, Osaka, Japan) were co-transfected with p-ss-EGFP-Adamts10
8
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(1 µg/well) and pmRFP-RECK (32) (1 µg/well) using Lipofectamine2000
and incubated for 2 days. Fluorescence signals were recorded using a
confocal microscope (Leica sp8).
In situ proximity ligation assay
Confluent NIH3T3 cells in 8-well chamber slides (8CS; SCS-008,
Matsunami) were fixed with IHC Zinc Fixative (BD Biosciences) for
4.5 h and subjected to PLA using Duolink Green (Sigma-Aldrich) with anti-
RECK (5B) and/or anti-ADAMTS10 (pAb-867) as primary antibodies and
anti-Mouse PLUS and anti-Rabbit MINUS as secondary antibodies. PLA
signals (green) and the number of nuclei (DAPI-stained) were quantified
using ImageJ (NIH).
Protein detection
Immunoblot assay was performed as described (Oh et al., 2001) using
α-tubulin as a control. Cell lysate was prepared using lysis buffer containing
50 mM Tris pH7.5, 0.5 M NaCl, 1% NP40, 0.1% SDS, 0.5% deoxycholate,
5 mM N-ethylmaleimide and 20×protease inhibitor cocktail (03969,
Nakarai, Kyoto, Japan). Samples were frozen at −80°C and just before
SDS-PAGE, boiled for 10 min in Laemmli sample buffer (1×) containing
83 mM DTT. Images were captured using LAS3000 (Fujifilm, Tokyo,
Japan). Densitometry was carried out using MultiGauge v3.2 (Fujifilm) or
ImageJ (NIH).
Protein-mixing assay
To test the effects of RECK and ADAMTS10 on each other (Fig. 3,
Figs S3 and S4), purified RECK-His (0.36 pmol), ATS10-MH (multiple
concentrations; ‘1’=0.72 pmol), or both in 20 µl Buffer E [150 mM NaCl,
5 mM CaCl2, 2.5 mM MgCl2, 0.5 mM ZnCl2, 0.05% Brij-35, 20 mM
Tris.HCl (pH 7.0), with or without 1 mM APMA] were incubated at 37°C
for the indicated period of time. To test the effects on FN (Fig. 4; Fig. S4),
mature MT1-MMP (0.31 pmol), RECK-His (0.48 pmol) and/or ATS10-
MH (0.43 pmol) were mixed in various combinations with FN (0.87 pmol)
and incubated at 37°C for the indicated period of time in 40 µl Buffer E. The
reaction mixture was separated by SDS-PAGE under non-reducing or
reducing conditions. To prepare mature MT1-MMP, recombinant MT1-
MMP (Millipore; CC1043, 230 ng) was pre-treated for 1 h with 20 ng furin
in 62 µl Buffer E.
Statistics
Significance of difference between two groups of data was evaluated using
Student’s t-test.
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